World Trade Factory™
Section

science

articles
Japan to foster space industry competition, looking for next SpaceX automated-news
Japan to foster space industry competition, looking for next SpaceX

Japan to foster space industry competition, looking for next SpaceX

03 Aug 2026 🔒
Senate appears ready to advance Blanche after Cornyn strikes deal automated-news
Senate appears ready to advance Blanche after Cornyn strikes deal

Sen. John Cornyn, R-Texas, a key holdout on confirming Todd Blanche for attorney general, struck a deal to end the controversial "anti-weaponization fund."

03 Aug 2026 🔒
AstraZeneca, Bristol-Myers: A $400 Billion Pharma Deal Could Get Really Messy automated-news
AstraZeneca, Bristol-Myers: A $400 Billion Pharma Deal Could Get Really Messy

Pascal Soriot has an awkward relationship with the UK. Now, the boss of AstraZeneca Plc is contemplating a megadeal with US peer Bristol-Myers Squibb Co. that could shift the British drugmaker’s center of gravity further westwards. It’s a potentially tricky tie-up. But Soriot’s counterintuitive bets

03 Aug 2026 🔒
AstraZeneca, Bristol-Myers: A $400 Billion Pharma Deal Could Get Really Messy automated-news
AstraZeneca, Bristol-Myers: A $400 Billion Pharma Deal Could Get Really Messy

Pascal Soriot has an awkward relationship with the UK. Now, the boss of AstraZeneca Plc is contemplating a megadeal with US peer Bristol-Myers Squibb Co. that could shift the British drugmaker’s center of gravity further westwards. It’s a potentially tricky tie-up. But Soriot’s counterintuitive bets

03 Aug 2026 🔒
Senate appears ready to advance Blanche after Cornyn strikes deal automated-news
Senate appears ready to advance Blanche after Cornyn strikes deal

Sen. John Cornyn, R-Texas, a key holdout on confirming Todd Blanche for attorney general, struck a deal to end the controversial "anti-weaponization fund."

03 Aug 2026 🔒
AstraZeneca Investors See Little Logic in Bristol Tie-Up automated-news
AstraZeneca Investors See Little Logic in Bristol Tie-Up

AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400 billion merger with Bristol-Myers Squibb Co. Bloomberg Intelligence's Director of Research, Sam Fazeli joins to discuss. (Source: Bloomberg)

03 Aug 2026 🔒
AstraZeneca, Bristol-Myers: A $400 Billion Pharma Deal Could Get Really Messy automated-news
AstraZeneca, Bristol-Myers: A $400 Billion Pharma Deal Could Get Really Messy

Pascal Soriot has an awkward relationship with the UK. Now, the boss of AstraZeneca Plc is contemplating a megadeal with US peer Bristol-Myers Squibb Co. that could shift the British drugmaker’s center of gravity further westwards. It’s a potentially tricky tie-up. But Soriot’s counterintuitive bets

03 Aug 2026 🔒
The Bio-Pharma Industry and Society automated-news
The Bio-Pharma Industry and Society

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

02 Aug 2026 🔒
The Bio-Pharma Industry and Society automated-news
The Bio-Pharma Industry and Society

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

02 Aug 2026 🔒
Jefferies ESG chief says investors overstate SpaceX governance risks automated-news
Jefferies ESG chief says investors overstate SpaceX governance risks

Jefferies ESG chief says investors overstate SpaceX governance risks

02 Aug 2026 🔒
📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.